The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Fuchs Heterochromic Iridocyclitis

Chronic, low-grade unilateral anterior uveitis with characteristic stellate keratic precipitates, iris heterochromia, posterior subcapsular cataract, and high incidence of glaucoma, often associated with rubella virus.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Göz Hastalıkları department. Book Appointment →

What is Fuchs Heterochromic Iridocyclitis?

FHI presents as chronic anterior uveitis with very mild inflammation that paradoxically does not respond well to topical corticosteroids — a key clinical clue. Mean age of onset is 30-40 years, with unilateral disease in 90% (rare bilateral cases described). Quiet inflammation belies progressive complications.

Pathognomonic findings: stellate keratic precipitates (diffuse, stellate-shaped, white-grey on the entire endothelium including superior cornea — unusual location), iris heterochromia (affected iris becomes lighter due to stromal atrophy and pigment loss), iris transillumination defects, fine iris vessels (Amsler sign — fine bleeding in anterior chamber during cataract surgery), and absence of posterior synechiae (despite chronic inflammation).

Etiology: rubella virus is now recognized as the major cause based on Goldmann-Witmer coefficient (intraocular antibody production) and PCR studies. Other proposed agents include toxoplasma (debated). Vaccination programs may reduce future incidence.

Symptoms

Painless, mild blurred vision (often gradual)
Floaters (vitreous involvement)
Asymptomatic minimal inflammation (often discovered incidentally)
Color difference between eyes (heterochromia, affected eye lighter — patient or family notices)
Decreased vision from cataract (most common reason for presentation)
Glaucoma-related vision loss in advanced disease
Absence of acute pain, redness, or photophobia (distinguishing from acute anterior uveitis)

Risk Factors

Age 20-50 years (peak 30-40)
Caucasian ancestry (more recognized but occurs in all races)
Lack of rubella vaccination (in some series)
No HLA association (unlike HLA-B27 acute anterior uveitis)
No systemic disease association (truly idiopathic-appearing)
Family history rare
Equal gender distribution

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Asymptomatic eye color change noticed by family or patient
  • Gradual blurred vision in one eye
  • Floaters or visual disturbances
  • Found incidentally on routine eye examination
  • Ophthalmology referral for chronic uveitis evaluation

Treatment Methods

01
Diagnostic confirmation: slit-lamp examination showing diffuse stellate KPs, iris heterochromia, absence of posterior synechiae, anterior chamber cells/flare; aqueous tap with rubella virus antibody analysis (Goldmann-Witmer coefficient) or PCR if diagnosis uncertain
02
Topical corticosteroids: minimal benefit; reserved for symptomatic flare-ups; risk of cataract progression and IOP elevation outweighs benefit in most cases
03
Cataract surgery: phacoemulsification with intraocular lens (IOL) implantation — generally well-tolerated despite chronic inflammation; expect Amsler sign (fine bleeding from iris vessels intraoperatively); preoperative pupil dilation may be poor; risk of postoperative cystoid macular edema
04
Postoperative management: topical NSAIDs and corticosteroids 1-3 months; close monitoring for IOP rise (steroid response common in FHI); excellent visual outcomes 80-90% achieve 20/40 or better
05
Glaucoma management: 30-50% develop secondary open-angle glaucoma over decades; topical IOP-lowering therapy first-line; selective laser trabeculoplasty modest benefit; trabeculectomy with antimetabolites (mitomycin C) for refractory cases; minimally invasive glaucoma surgery (XEN, iStent) emerging
06
Vitreous opacities: usually require no treatment; vitrectomy for visually significant floaters
07
Intravitreal corticosteroid: rarely indicated; reserved for cystoid macular edema
08
Systemic immunosuppression: not indicated for typical FHI (low-grade chronic inflammation)
09
Long-term monitoring: routine eye examinations every 6-12 months for cataract and glaucoma surveillance, gonioscopy annually
10
Patient education: chronic but generally benign nature, expectation of cataract surgery in many patients, importance of glaucoma monitoring
11
Differential diagnosis maintenance: distinguish from herpetic uveitis (sectoral iris atrophy, IOP spikes), Posner-Schlossman syndrome (acute IOP rise), HLA-B27 anterior uveitis, sympathetic ophthalmia

Which Department to Visit?

You can visit our Göz Hastalıkları department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Göz Hastalıkları Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.